We have prepared a construct (designated CATTNF) in which the mouse TNF (cachectin) coding sequence is replaced by a sequence encoding chloramphenicol acetyltransferase (CAT), with preservation of the TNF promoter and 3'-untranslated sequences known to be important in the regulation of gene expression. When activated by LPS, permanently transfected RAW 264.7 (mouse macrophage) cells synthesize large quantities of CAT. Unlike TNF itself, CAT is nonsecreted and quite stable in the macrophage cytoplasm. Fewer than 1,000 LPS-induced macrophages can easily be detected by CAT assay. Cells maintain the ability to respond to LPS in vivo; as such, when injected intravenously, they accurately report conditions required for the production of TNF in diverse tissues. These cells may thus be used for the detection of cachectin/TNF synthesis in mice under conditions in which endogenously produced cachectin/TNF would be undetectable. Studies of the expression of CATTNF in nonmacrophage cell lines have revealed that the modified TNF gene is constitutively expressed in L-929 cells, but that its expression is tightly suppressed in HeLa cells and in NIH 3T3 cells. This finding would suggest that certain nonmacrophage cells are potentially capable of utilizing the TNF promoter and translating the TNF mRNA; however, the endogenous gene has been developmentally silenced.
Introduction
It is widely accepted that TNF (also referred to as cachectin) is an important mediator ofdiverse inflammatory processes. The role of TNF in endotoxic shock has been established both by passive immunization studies (1) (2) (3) , and by experiments in which the protein was directly administered to animals (4) . Similar work has implicated this cytokine in the pathogenesis of cerebral malaria (5) , the acute phase of graft-versus-host (GVH) disease (6) , bleomycin-induced pulmonary toxicity (7, 8) , and other disease states as well (9, 10) . It has been suggested that TNF may play an essential role as a mediator of wasting (1 1, 12) and dyserythropoiesis ( 13, 14) in chronic disease. It is suspected that TNF may also be involved in numerous chronic inflammatory illnesses, both of infectious and noninfectious etiology.
The sine qua non of "involvement," of course, is the production of TNF. Only if the cytokine is elaborated in a given disease state may it be said to play a role. In many instances, efforts to demonstrate the production of TNF through bioassays or immunologically based assays performed on biological fluids derived from human or animal subjects with various diseases or disease models have yielded negative results, and the presence of the hormone may only be inferred through passive immunization experiments.
It is not possible, for example, to document the presence of TNF in mice infected with Bacillus Calmette-Guerin, or in mice with GVH disease, although passive immunization studies suggest its presence (6, 10) . It is also impossible to detect circulating TNF in animals with focal infections or inflammatory lesions. This failure might be explained on the basis of several considerations:
(a) TNF, though abundantly produced in response to bacterial endotoxin (1 1), is produced in far smaller quantities in response to all other known stimuli.
(b) Production is, at least under some circumstances, transient.
(c) A very small volume of tissue may be involved in the inflammatory reaction so that the protein is greatly diluted in the systemic circulation.
(d) The protein is efficiently exported from the cell, leaving little evidence of its production at the secretory site. Thus, immunohistochemical detection of TNF is an exceedingly difficult proposition, further complicated by the fact that an inactive (15) membrane-associated (16) form of TNF has been described.
(e) TNF is produced by extravascular effector cells (chiefly macrophages and, to a lesser extent, lymphocytes), and much of it may never gain access to the circulation.
(f) Circulating inhibitors of TNF, notably a soluble form of the TNF receptor (17, 18) , have been described, which may interfere with the biological assay of TNF, and perhaps with immunologic detection, as well, under some circumstances.
(g) In circulation, the murine protein has a half-life of 6 min (19) . Attempts to assess the production ofTNF by measurement of TNF mRNA in animal tissues have been frustrated by the fact that TNF mRNA can exist in an untranslated form (20) ; hence, normal tissues contain the mRNA in detectable quantities (21), while there is no assurance that the protein is being synthesized. Indeed, much of the biosynthetic regulation of TNF production has been shown to occur at a translational level in vitro (22) .
We considered that many of the problems inherent in the measurement of TNF For some studies, a promoterless version of the construct was used. The TNF promoter was deleted from the construct by cleaving the construct with KpnI and Clal (a unique site within the linker), blunting the ends, and religating.
Cell culture. RAW 264.7 cells, obtained from the American Type Culture Collection, were grown in DMEM supplemented with 5% fetal bovine serum (Gibco Laboratories, Grand Island, NY). Cells were split when they reached confluence by rinsing them with Dulbecco's PBS and allowing them to soak in a second change of PBS for several minutes, after which they were readily removed from the plate by trituration. L-929 cells (to be used both for transfection and for the TNF bioassay), HeLa cells, and NIH3T3 cells were grown in DMEM supplemented with 10% FBS.
Penicillin and streptomycin solution (Gibco Laboratories) were added to all cultures at a final concentration of 4%.
Transfection. RAW 264.7 cells were transfected as described elsewhere (22) . 10 ,g of vector containing the CAT marker and 10 jig of pSV2neo were mixed and precipitated with calcium phosphate. 106 cells were transfected, subjected to glycerol shock, and allowed to recover for 48 h. Selection with G418 (1 mg/ml) was carried out over the next 3 wk, by which time visible colonies had formed.
HeLa cells, L-929 cells, and NIH3T3 cells were transfected using the technique described by Chen and Okayama (25) . The same quantity of DNA was employed as in the case of RAW 264.7 cell transfections. Pooled G41 8-resistant clones were used for CAT assay. DNA was prepared from these cell types to document that reporter gene transfection had occurred.
Induction of TNF and CA T expression by LPS. E. coli LPS (strain 0127:B8) was obtained from Gibco Laboratories. Cells were induced by adding LPS to a final concentration of I Ag/ml unless otherwise noted, for the stated period of time.
TNF bioassay. Bioassay of TNF produced by transfected RAW 264.7 cells, or TNF present in serum, was carried out as previously described (15) in 96-well plates using cycloheximide (0.1 mg/ml) to potentiate the cytotoxic effect. Cytotoxicity was assessed by staining the residual cells with crystal violet. Measurements were performed using a microplate reader and interpreted with reference to a standard preparation of recombinant human TNF.
In vivo studies of CAT synthesis. Female BALB/c mice, -25 g each, were used in these experiments.
RAW 264.7 cells bearing the CAT construct were chromium labeled for a period of 10 min at room temperature, and washed twice before intravenous injection into animals; 2 x 10' cells were injected per mouse. In preliminary experiments, distribution of the chromium label was followed over time; in subsequent experiments, some of the mice were injected intraperitoneally with 500 Mug of LPS (approximately one LD50 dose) 2 h after injection of the cell suspension; controls received no injection. The animals were bled and then killed by CO2 narcosis 4 h later.
Tissues were weighed upon removal, homogenized in 0.25 M Tris, pH 7.8, frozen, thawed, and centrifuged at 12,000 g to remove insoluble material. The supernatant was then assayed for protein, and subsequently heated to 65°C for 5 min. After a second centrifugation, the supernatant was subjected to CAT assay and counted to quantitate the chromium label.
CA T assay. The thin layer chromatography procedure ofGorman, et al. (26) was used to measure CAT activity in cell lysates, derived from either peritoneal tumors or from cultured cells.
DNA isolation. DNA was prepared from transfected cells as elsewhere described (27).
Measurement ofthe half-life ofCA Tsynthesized within RA W264. 7 cells. Cultured cells were plated in 3-cm dishes, rinsed with DMEM, and then overlayed with prewarmed medium containing [35S]-methionine (Amersham Corp., Arlington Heights, IL) and LPS. After a 4-h incubation, cells were washed with prewarmed DMEM containing unlabeled methionine, supplemented with 5% FBS, and either main-tained in the presence or absence of LPS. Cells were harvested by trituration with PBS, pelleted, and resuspended in a solution containing 140 mM NaCi, 1.5 mM MgCI2, and 10mM tris, pH 8.6. The cells were then lysed by the addition of an equal volume of the same solution containing 1% NP40. The nuclei were removed by centrifugation, and rabbit anti-CAT serum (2 l; obtained from 5'-. 3', Inc.) was added to each sample for a period of 2 h at 0C, followed by pansorbin (Calbiochem-Behring Corp., San Diego, CA; 30 Ml of a 10% suspension). The pansorbin was pelleted after an additional 1 h of incubation, resuspended in 1 ml of PBS containing 0.25% SDS, then repelleted and washed five times with a solution containing 10 mM tris, pH 7.5, 150 mM NaCI, 10 mM EDTA, 0.25% SDS, and 0.5% NP40. The pellet was then washed a final time in PBS, pelleted, and resuspended in 40 Al of 10 mM tris, I mM EDTA solution. After addition of 40 Al of SDS sample buffer, each sample was boiled for 5 min and subjected to electrophoresis in a polyacrylamide gel (28) , poured as a 10-15% gradient. The gel was soaked in Enlightening (DuPont Co., Wilmington, DE), dried, and used for autoradiography. Densitometric analysis ofthe exposed film was carried out using a Gilford Response spectrophotometer (C. N. Wood Manufacturing Co., Newtown, PA).
Results
The construct employed in these experiments is illustrated in Fig. 1 . It contains sequence encoding the last 135 amino acid of the lymphotoxin protein, the lymphotoxin 3'-untranslated region, the DNA sequence lying between lymphotoxin and TNF (which contains the TNF promoter), most of the 5'-untranslated sequence derived from TNF, a short linker connecting the TNF 5'-untranslated region to CAT, the CAT coding sequence, the 3'-untranslated sequence ofTNF, and -200 bp of DNA lying downstream from the poly-A signal sequence. Thus, all of the principal regulatory elements presently known to affect TNF synthesis are included.
Transfection of RAW 264.7 cells with CA TTNF. After cotransfection of this construct (together with pSV2neo) into RAW 264.7 cells, G4 18 selection was performed, and a pool of resistant cells was obtained from -40 primary clones. Highly inducible expression of CAT was observed in the pool after exposure to endotoxin; the ratio ofCAT activity (induced/noninduced) was 4,000:1. Subclones of the pool were obtained by limiting dilution of the parent culture, and many were found to be similarly inducible (Fig. 2) . Clone 23 was selected Figure 1 . The CAT construct used as a reporter of TNF biosynthesis. For most applications, the construct was cloned into the vector Bluescript KS between KpnI and SmaI sites. 5' sequences from the CAT genblock preceed the initiation codon of CAT, and replace some of the 5'-untranslated sequence of TNF as described in the text. The 3'-untranslated region of mouse TNF was inserted exactly after the termination codon of CAT (e.g., the termination codons of TNF and CAT are superimposed). Solid for all of the experiments described below. By Southern blot analysis, it was found to contain -10 copies of the marker gene per genome (Fig. 3) .
Induction ofCAT biosynthesis by endotoxin. Endotoxin induces CAT expression in RAW 264.7 cells over a period of time similar to that required for TNF induction (Fig. 4) . Cellassociated CAT activity declines after 16 h in the presence of endotoxin (not shown). However, measurements ofCAT activity in the culture medium suggest that this may be partly attributable to cell lysis. Indeed, LPS is known to exert a strong cytotoxic effect upon RAW 264.7 cells (29) . The biosynthesis of CAT also mimics TNF production by a culture when examined with respect to endotoxin concentration; exposure ofcultured cells to increasing quantities of LPS led to the coordinate induction of CAT and TNF (Fig. 5) . In neither case was the relationship between CAT and TNF perfectly linear; this may be explained, in part, by the fact that TNF is cleared from a culture by binding to its cell-surface receptor. CAT activity was induced in the cultures by concentrations of LPS that were insufficient to induce the secretion of detectable quantities of TNF. Thus, the CAT assay is a more sensitive indicator of macrophage activation than the TNF bioassay.
The quantity of CAT present in RAW 264.7 cells was such that 1,000 maximally-induced cells could be detected by a 2-h CAT assay, with an overnight exposure of the film (Fig. 6 ).
The half-life of CAT within cultured RAW 264.7 cells was determined by pulse labeling during a 4-h period of exposure to LPS, with immunoprecipitation of the labeled product at various times thereafter. After labeling, cells were maintained in the presence or absence of LPS (Fig. 7) . In either case, densitometric data (not shown) indicated that CAT was cleared from the cytoplasm with biphasic kinetics: an initial rapid loss of CAT protein (t1/2 of 1-2 h) was followed by a slow phase of loss (t1/2 of 10-20 h), suggesting that distinct pools of the reporter might exist within these cells.
In short term experiments, transfected RA W 264.7 cells report the biosynthesis of TNF in vivo. In order to utilize the transfected RAW 264.7 cells as a reporter of TNF biosynthesis in vivo, cultured cells were chromium labeled and injected intravenously into BALB/c mice. The majority of the cells were recovered from the lung 30 min after injection; however, redistribution occurred so that within 2 h, many of the cells had migrated to the liver, spleen, and other organs (data not shown). When mice were injected with LPS subsequent to infusion of the reporter cells, and then sacrificed several hours later, strong induction of CAT activity was observed in many of the organs examined (Fig. 8) (Fig. 9 a) by Southern blot analysis (Figs. 9 a, and b) . At the level of mRNA expression, the endogenous TNF gene appears silent in each of these lines (Fig. 9 c) (Fig. 10) . However, when genomic DNA obtained from the older culture was digested with KpnI and SmaI, two bands were visualized; cells frozen at an early stage of culture displayed only one band. The size ofthe bands (-4 and 7 kb) suggested an explanation, in that failure to cleave at KpnI or SmaI sites would lead to excision of the vector together with the reporter construct (e.g., a 7-kb fragment would result instead of the expected 4-kb fragment). Since SmaI is a methylation-sensitive enzyme, we have tentatively concluded that a fraction ofthe SmaI sites present in the integrated reporter construct were methylated, and further inferred that the entire insert had been modified by methylation.
HeLa and NIH3T3 cells, in which the reporter construct is not expressed, were subsequently examined for evidence of insert methylation using a panel of methylation-sensitive enzymes, although no indication of SmaI site methylation was apparent (Fig. 9 b) . All of the enzymes tested (AccI, Aval, AvaII, BglII, HpaII, MspI, Sau3A, and XbaI) produced fragments of the expected sizes, thus providing no evidence of methylation (not shown).
Discussion
We have produced a construct in which the coding sequence of TNF is replaced by the coding sequence of CAT, and have shown that this construct functions as a nonsecreted marker of TNF biosynthesis in transfected macrophages. In the near term following transfection, CAT may be measured with high sensitivity, such that 1,000 fully activated cells may easily be detected. In vitro, expression of CAT activity is strongly suppressed in the absence of an activating stimulus. Thus, an induction ratio of 4,000 is observed in the most inducible b. CAT (% Acetylation) (b) In RAW 264.7 macrophages, the reporter gene (like the TNF gene that it was designed to mimic) is strongly suppressed in unstimulated cells, but is readily induced by endotoxin. Taken together with other data suggesting the existence of suppressor mechanisms regulating the expression of TNF at both transcriptional (34) and translational levels (20, 23) , it may be concluded that TNF gene expression is reversibly suppressed in macrophages; however, mechanisms that promote derepression may be activated by LPS.
(c) In HeLa cells, and in NIH3T3 cells, neither the reporter gene nor the authentic TNF gene are expressed, either in the absence or presence of LPS. The status of the authentic TNF gene, with respect to developmental inactivation, cannot readily be established in these cell types. However, the inactivity of the reporter gene (despite a lack of evidence of methylation) is curious, and suggests that in these cells, as in macrophages, a system for the repression ofTNF biosynthesis may be in place. It may further be assumed that the activating mechanism normally triggered by LPS is not functional.
Thus, two general mechanisms of TNF gene repression seem to apply in somatic cells. One appears to have a developmental basis, and is not reversed by treatment with LPS. The second repressor mechanism may apply in many tissues; it exhibits both transcriptional (34) and translational (23, 35) LPS (not shown), a far higher induction ratio is witnessed after inclusion of the 3'-untranslated region (e.g., 4,000-fold in this study). Conceivably, other elements of the TNF gene, contained within the introns, might further augment the response.
The genetic marker that we have produced and characterized affords many opportunities in TNF research. It may, for example, facilitate the study of macrophage responses and the analysis of permanent macrophage cell lines. It may also help to clarify whether certain other cell types can, in fact, produce TNF, and may serve as a signpost of macrophage differentiation. Of still greater importance, however, is the potential use of this construct, or a similar one in transgenic animals, in which it may faithfully report the production ofTNF whenever and wherever it occurs in vivo.
Among many questions that might be answered through the use of CATTNF constructs, it may be possible to ascertain the principal tissue sources of TNF as it is produced in endotoxemic animals. It will be possible to examine the autonomous production of TNF by tumors or by immune cells reacting to tumors. It may also be possible to determine whether the protein is produced in various inflammatory diseases, both acute and chronic in character, and in diseases in which inflammation occurs in an anatomically restricted pattern (e.g., focal infections and circumscribed autoimmune processes). The CAT activity by non 
